United Therapeutics | UTHR - Trade Debtors


United Therapeutics reported $297.7M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Amarin USD 127.31M 8.18M Sep/2025
Ardelyx USD 76.61M 14.06M Sep/2025
Baxter International USD 2.01B 231M Dec/2025
Bayer EUR 14.91B 2.73B Sep/2025
BioCryst Pharmaceuticals USD 79.07M 6.61M Dec/2024
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
J&J USD 17.61B 235M Sep/2025
Lexicon Pharmaceuticals USD 2.62M 1.09M Jun/2024
Moderna USD 184M 862M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025
United Therapeutics USD 297.7M 81.6M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025